Blood basophils from cystic fibrosis patients with allergic bronchopulmonary aspergillosis are primed and hyper-responsive to stimulation by aspergillus allergens

Journal of Cystic Fibrosis

Volumn 11, Issue 6, 2012, Pages 502-510

  Gernez, Yael ^a   Dunn, Colleen E ^a   Everson, Cassie ^a   Mitsunaga, Erin ^a   Gudiputi, Lakshmi ^a   Krasinska, Karolina ^b   Davies, Zoe A ^a   Herzenberg, Leonore A ^a   Tirouvanziam, Rabindra ^c   Moss, Richard B ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Degranulation; FACS; Granulocytes; Inflammation; Lung disease

Indexed keywords

ALLERGEN; ANTIGEN; ASPERGILLUS ALLERGEN; CD123 ANTIGEN; CD203C ANTIGEN; CD63 ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ARTICLE; ASPERGILLUS FUMIGATUS; BASOPHIL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; FLOW CYTOMETRY; FUNGAL COLONIZATION; HUMAN; LUNG FIBROSIS; MALE; NONHUMAN; PRESCHOOL CHILD; SCHOOL CHILD; UPREGULATION;

ADOLESCENT; ADULT; ALLERGENS; ANTIGENS, CD63; ANTIGENS, FUNGAL; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; ASPERGILLUS FUMIGATUS; BASOPHILS; CELL DEGRANULATION; CHEMOKINE CCL17; CHILD; CYSTIC FIBROSIS; FEMALE; FLOW CYTOMETRY; FUNGAL PROTEINS; HUMANS; INTERLEUKIN-3 RECEPTOR ALPHA SUBUNIT; MALE; PHOSPHORIC DIESTER HYDROLASES; PYROPHOSPHATASES; RECOMBINANT PROTEINS; YOUNG ADULT;

EID: 84869087283     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2012.04.008     Document Type: Article

References (36)

1. Davis P.B. Cystic fibrosis since 1938. Am J Respir Crit Care Med Mar 1 2006, 173(5):475-482.
2. Tirouvanziam R. Neutrophilic inflammation as a major determinant in the progression of cystic fibrosis. Drug News Perspect 2006, 19(10):609-614.
3. Gilligan P.H. Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev Jan 1991, 4(1):35-51.
4. Mortensen K.L., Jensen R.H., Johansen H.K., Skov M., Pressler T., Howard S.J., et al. Aspergillus species and other molds in respiratory samples from patients with cystic fibrosis: a laboratory-based study with focus on Aspergillus fumigatus azole resistance. J Clin Microbiol Jun 2011, 49(6):2243-2251.
5. Moss R.B. Allergic bronchopulmonary aspergillosis and Aspergillus infection in cystic fibrosis. Curr Opin Pulm Med Nov 2010, 16(6):598-603.
6. Pihet M., Carrere J., Cimon B., Chabasse D., Delhaes L., Symoens F., et al. Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis-a review. Med Mycol Jun 2009, 47(4):387-397.
7. Agarwal R. Allergic bronchopulmonary aspergillosis. Chest Mar 2009, 135(3):805-826.
8. Amin R., Dupuis A., Aaron S.D., Ratjen F. The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. Chest Jan 2010, 137(1):171-176.
9. de Vrankrijker A.M., van der Ent C.K., van Berkhout F.T., Stellato R.K., Willems R.J., Bonten M.J., et al. Aspergillus fumigatus colonization in cystic fibrosis: implications for lung function?. Clin Microbiol Infect Sep 2011, 17(9):1381-1386.
10. Shoseyov D., Brownlee K.G., Conway S.P., Kerem E. Aspergillus bronchitis in cystic fibrosis. Chest Jul 2006, 130(1):222-226.
11. Kraemer R., Delosea N., Ballinari P., Gallati S., Crameri R. Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis. Am J Respir Crit Care Med Dec 1 2006, 174(11):1211-1220.
12. Moss R.B. Allergic bronchopulmonary aspergillosis. Aspergillus fumigatus and Aspergillosis 2009, 333-350. American Society of Microbiology Press, Washington DC. S.W.J. Latge (Ed.).
13. Rapaka R.R., Kolls J.K. Pathogenesis of allergic bronchopulmonary aspergillosis in cystic fibrosis: current understanding and future directions. Med Mycol 2009, 47(Suppl. 1):S331-S337.
14. Nagano Y., Millar B., Johnson E. Fungal infections in patients with cystic fibrosis. Rev Med Microbiol 2007, 18:11-16.
15. Delhaes L., Frealle E., Pinel C. Serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis: State of the art and further challenges. Med Mycol Nov 2010, 48(Suppl. 1):S77-S87.
16. Stevens D.A., Moss R.B., Kurup V.P., Knutsen A.P., Greenberger P., Judson M.A., et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis-state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis Oct 1 2003, 37(Suppl. 3):S225-S264.
17. Ricketti A.J., Greenberger P.A., Pruzansky J.J., Patterson R. Hyperreactivity of mediator-releasing cells from patients with allergic bronchopulmonary aspergillosis as evidenced by basophil histamine release. J Allergy Clin Immunol Oct 1983, 72(4):386-392.
18. MacGlashan D. Expression of CD203c and CD63 in human basophils: relationship to differential regulation of piecemeal and anaphylactic degranulation processes. Clin Exp Allergy Sep 2010, 40(9):1365-1377.
19. Abuaf N., Rajoely B., Ghazouani E., Levy D.A., Pecquet C., Chabane H., et al. Validation of a flow cytometric assay detecting in vitro basophil activation for the diagnosis of muscle relaxant allergy. J Allergy Clin Immunol Aug 1999, 104(2 Pt 1):411-418.
20. Buhring H.J., Seiffert M., Giesert C., Marxer A., Kanz L., Valent P., et al. The basophil activation marker defined by antibody 97A6 is identical to the ectonucleotide pyrophosphatase/phosphodiesterase 3. Blood May 15 2001, 97(10):3303-3305.
21. Vichyanond P. Omalizumab in allergic diseases, a recent review. Asian Pac J Allergy Immunol Sep 2011, 29(3):209-219.
22. Ciepiela O., Zwiazek J., Zawadzka-Krajewska A., Kotula I., Kulus M., Demkow U. Basophil activation test based on the expression of CD203c in the diagnostics of cow milk allergy in children. Eur J Med Res Nov 4 2010, 15(Suppl. 2):21-26.
23. Tokuda R., Nagao M., Hiraguchi Y., Hosoki K., Matsuda T., Kouno K., et al. Antigen-induced expression of CD203c on basophils predicts IgE-mediated wheat allergy. Allergol Int Jun 2009, 58(2):193-199.
24. Abuaf N., Rostane H., Rajoely B., Gaouar H., Autegarden J.E., Leynadier F., et al. Comparison of two basophil activation markers CD63 and CD203c in the diagnosis of amoxicillin allergy. Clin Exp Allergy Jun 2008, 38(6):921-928.
25. Binder M., Fierlbeck G., King T., Valent P., Buhring H.J. Individual hymenoptera venom compounds induce upregulation of the basophil activation marker ectonucleotide pyrophosphatase/phosphodiesterase 3 (CD203c) in sensitized patients. Int Arch Allergy Immunol Oct 2002, 129(2):160-168.
26. Arruda L.K., Platts-Mills T.A., Fox J.W., Chapman M.D. Aspergillus fumigatus allergen I, a major IgE-binding protein, is a member of the mitogillin family of cytotoxins. J Exp Med Nov 1 1990, 172(5):1529-1532.
27. Marchant J.L., Warner J.O., Bush A. Rise in total IgE as an indicator of allergic bronchopulmonary aspergillosis in cystic fibrosis. Thorax Oct 1994, 49(10):1002-1005.
28. Gernez Y., Tirouvanziam R., Reshamwala N., Yu G., Weldon B.C., Galli S.J., et al. Modulation of mTOR Effector Phosphoproteins in Blood Basophils from Allergic Patients. J Clin Immunol Feb 2012, 21.
29. Gernez Y., Tirouvanziam R., Yu G., Ghosn E.E., Reshamwala N., Nguyen T., et al. Basophil CD203c levels are increased at baseline and can be used to monitor omalizumab treatment in subjects with nut allergy. Int Arch Allergy Immunol 2011, 154(4):318-327.
30. Yasnowsky K.M., Dreskin S.C., Efaw B., Schoen D., Vedanthan P.K., Alam R., et al. Chronic urticaria sera increase basophil CD203c expression. J Allergy Clin Immunol Jun 2006, 117(6):1430-1434.
31. Fricker-Hidalgo H., Coltey B., Llerena C., Renversez J.C., Grillot R., Pin I., et al. Recombinant allergens combined with biological markers in the diagnosis of allergic bronchopulmonary aspergillosis in cystic fibrosis patients. Clin Vaccine Immunol Sep 2010, 17(9):1330-1336.
32. Latzin P., Hartl D., Regamey N., Frey U., Schoeni M.H., Casaulta C. Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis. Eur Respir J Jan 2008, 31(1):36-42.
33. Williams C., Lucas C., Davies P., Ramage G., McCulloch E. Utility of TARC in serodiagnosis of ABPA in a paediatric CF population. J Cyst Fibros 2011, 10(Suppl. (1)):S37.
34. Kelly M.T., Martin R.R., White A. Mediators of histamine release from human platelets, lymphocytes, and granulocytes. J Clin Invest May 1971, 50(5):1044-1049.
35. Crameri R., Hemmann S., Ismail C., Menz G., Blaser K. Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis. Int Immunol Aug 1998, 10(8):1211-1216.
36. Regamey N., Tsartsali L., Hilliard T.N., Fuchs O., Tan H.L., Zhu J., et al. Distinct patterns of inflammation in the airway lumen and bronchial mucosa of children with cystic fibrosis. Thorax Feb 2012, 67(2):170-176.